Cepheid (NASDAQ:CPHD)

CAPS Rating: 3 out of 5

A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.

Recs

0
Player Avatar lovesaves (80.26) Submitted: 1/21/2012 4:01:55 PM : Underperform Start Price: $43.44 CPHD Score: +1.13

High P/E, High PEG and High P/B.

Featured Broker Partners


Advertisement